abstract |
This invention relates to (e)-@-[2-n-butyl-1-[4-carboxyphenyl)methyl]-1h-imidazol-5-yl]methylene-2-thiophenepropionic acid monomethanesulfonate dihydrate, a process for its production, compositions containing the compound and methods of using the compound to block angiotensin ii receptors and to treat hypertension, congestive heart failure and renal failure. |